Document Detail

Activatable Cell Penetrating Peptide-Conjugated Nanoparticles with Enhanced Permeability for Site-Specific Targeting Delivery of Anticancer Drug.
MedLine Citation:
PMID:  23350619     Owner:  NLM     Status:  Publisher    
Based on the powerful cell-penetrating ability of low molecular weight protamine (LMWP) and the over-expression of matrix metalloproteinases in the tumor sites, we here constructed an activatable low molecular weight protamine (ALMWP) and modified it onto the surface of PEG-PLA nanoparticles to develop a 'smart' drug delivery system with enhanced permeability for facilitating site-specific targeting delivery of anticancer drug. The obtained ALMWP-NP with a particle size of 134.0 ± 4.59 nm and a zeta potential of -34.4 ± 2.7 mV, exhibited an enhanced MMP-dependent accumulation in HT-1080 cells via both energy-independent direct translocation and clathrin-mediated, cytoskeleton-dependent endocytosis. Pharmacokinetic and biodistribution study in HT-1080 tumor-bearing mice showed that ALMWP-NP significantly increased the accumulation of paclitaxel (PTX) in the tumor site but not the non-target tissues. In addition, intra-tumor distribution analysis demonstrated that more ALMWP-NP penetrated deeply into the tumor parenchyma. As a result, PTX loaded by ALMWP-NP exhibited improved anti-tumor efficacy over that by NP and LMWP-NP. The findings suggested that ALMWP-NP could be used as a safe and effective tumor-targeting drug delivery system and opened a new gateway to the application of cell-penetrating peptides for targeted anti-tumor therapy.
Huimin Xia; Guangzhi Gu; Quanyin Hu; Zhongyang Liu; Mengyin Jiang; Ting Kang; Deyu Miao; Qingxiang Song; Lei Yao; Yifan Tu; Hongzhuan Chen; Xiaoling Gao; Jun Chen
Related Documents :
2547519 - Directed migration of murine and human tumor cells to collagenases and other proteases.
12359359 - Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metas...
10362139 - Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic lpa).
11106549 - Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during...
18587209 - Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vi...
9761939 - Fibrinolytic activity of earthworms extract (g-90) on lysis of fibrin clots originated ...
2418689 - Adrenocortical carcinoma. an immunohistochemical comparison with renal cell carcinoma.
8758919 - Antibody penetration of tumor gs-7 xenografts in nude mice: a model for mucinous adenoc...
18021179 - Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen recepto...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-28
Journal Detail:
Title:  Bioconjugate chemistry     Volume:  -     ISSN:  1520-4812     ISO Abbreviation:  Bioconjug. Chem.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9010319     Medline TA:  Bioconjug Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence of congenital heart disease at live birth: an accurate assessment by echocardiographic sc...
Next Document:  Cu-Catalyzed Enantioselective Allyl-Allyl Cross Coupling.